Skip to Content

Azathioprine Tablets

Last Updated: September 15, 2015
Status: Current

Products Affected - Description

Azathioprine tablets, Roxane
50 mg tablets, 100 count bottle (NDC 00054-4084-25) - discontinued
50 mg tablets, 100 count unit-dose (NDC 00054-8084-25) - discontinued

Reason for the Shortage

  • Roxane discontinued azathioprine tablets in mid-January 2015 due to problems obtaining active ingredient.
  • Valeant acquired Salix Pharmaceuticals in April 2015.
  • Mylan could not provide a reason for the shortage.
  • Prometheus Laboratories states the reason for the shortage was increased demand.

Available Products

Azasan tablets, Valeant (formerly Salix)
75 mg tablets, 100 count bottle (NDC 65649-0231-41)
100 mg tablets, 100 count bottle (NDC 65649-0241-41)

 
Imuran tablets, Prometheus Laboratories
50 mg tablets, 100 count bottle (NDC 65483-0590-10)
 
Azathioprine tablets, Mylan
50 mg tablets, 50 count unit-dose (NDC 51079-0620-06)
50 mg, 100 count (NDC 00378-1005-01)
 
Azathioprine tablets, Zydus
50 mg tablets, 100 count bottle (NDC 68382-0003-01)
50 mg tablets, 500 count bottle (NDC 68382-0003-05)

Estimated Resupply Dates

All suppliers have product available.

Related Shortages

Updated

September 15, July 9, June 18, 11 and 8, May 13, April 27, March 18, February 11, January 9, 2015; December 5, October 3, August 29, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide